01 1VERTEX PHARMS
02 26VERTEX PHARMS INC
01 279670163
01 27Blank
01 27Y
01 272026-12-28
Patent Expiration Date : 2026-12-28
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 9670163
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212273
Patent Use Code : U-4078
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-12-28
Patent Expiration Date : 2026-12-28
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 9670163
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-3591
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-12-28
Patent Expiration Date : 2026-12-28
US Patent Number : 9670163
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 211358
Patent Use Code : U-2376
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-12-28
Patent Expiration Date : 2026-12-28
US Patent Number : 9670163
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 211358
Patent Use Code : U-2376
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-12-28
Patent Expiration Date : 2026-12-28
US Patent Number : 9670163
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207925
Patent Use Code : U-1311
Delist Requested :
Patent Use Description : METHOD OF TREATING CYS...
Patent Expiration Date : 2026-12-28
Patent Expiration Date : 2026-12-28
US Patent Number : 9670163
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206038
Patent Use Code : U-1911
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-12-28
Patent Expiration Date : 2026-12-28
US Patent Number : 9670163
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207925
Patent Use Code : U-1311
Delist Requested :
Patent Use Description : METHOD OF TREATING CYS...
Patent Expiration Date : 2026-12-28
Patent Expiration Date : 2026-12-28
US Patent Number : 9670163
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207925
Patent Use Code : U-2530
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-12-28
Patent Expiration Date : 2026-12-28
US Patent Number : 9670163
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207925
Patent Use Code : U-3606
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-12-28
Patent Expiration Date : 2026-12-28
US Patent Number : 9670163
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207925
Patent Use Code : U-3606
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-12-28
